November 25th, 2014

The Fight Against Pediatric HIV and AIDS Goes On

by Karen Manson, Senior Director, Janssen Global Citizenship & Sustainability

Editors note: World AIDS Day, December 1, serves as a reminder that while significant progress has been made in the global battle against HIV/AIDS, there is still much more to be done and we must recommit to the goal of Getting to Zero.  Johnson & Johnson, driven by our purpose of caring, remains committed to the prevention, detection, education and treatment of HIV/AIDS.   As a transformational medical innovator Janssen, the pharmaceutical companies of Johnson & Johnson, is committed to developing comprehensive solutions against HIV/AIDS – to combat resistance; simplify treatment; discover and develop new medicines for HIV, and conduct early research toward fulfilling the dream of an HIV vaccine or a cure.  Through the Janssen Global Public Health HIV Medicines Access and Partnerships Program our efforts to ensure affordable and sustainable access to our HIV medicines in least developed countries are working.   During the course of 2014 we launched a collaborative commitment, New Horizons Advancing Pediatric HIV Treatment, to build awareness and incite action around the unmet needs of HIV treatment-experienced children and adolescents in sub-Saharan Africa.  In addition we have more than 100 philanthropic programs in more than 50 least developed countries that attempt to address the needs of those affected by HIV/AIDS. 

Read More

November 19th, 2014

For the Children’s Future

by Joaquin Duato, Worldwide Chairman, Janssen Pharmaceutical Companies of Johnson & Johnson, and Sarah Colamarino, Vice President, Corporate Equity Programs, Johnson & Johnson

Duato-1

As parents, both of us agree that no investment is more important than our children’s future. Every child-no matter where he or she is born-should survive and thrive. Whether during the early moments of life or through their important developmental years, children around the world can have healthier, happier futures.

That’s why this evening was a special night for all of us at Johnson & Johnson. Our Chairman and CEO Alex Gorsky, plus senior company leadership, joined hundreds of supporters at the Save the Children Illumination Gala, where we made a significant announcement to inspire the survival and healthy development of children under 5, with a focus on newborns. Johnson & Johnson is committing a minimum of $10 million over three years to help expand resources, with a particular focus on “Helping Babies Breathe.” This commitment is a natural expansion of the partnership that Johnson & Johnson and Save the Children have enjoyed for more than 20 years.

Alex Gorsky

© AEFletcher 2014

While the first day of a baby’s life is always a joyous one, it also can be a precarious one.

Read More

November 19th, 2014

Supporting World COPD Day

World COPD Day Infographic

Today, November 19th, Janssen proudly supports World Chronic Obstructive Pulmonary Disorder (COPD) Day, an annual event organized by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) to raise awareness and improve care for obstructive lung diseases.

COPD is a progressive lung disease that interferes with airflow, making it difficult to breathe. Emphysema and chronic bronchitis are terms often used to describe types of COPD. More than 64 million people worldwide are living with COPD, and while core symptoms include cough, phlegm, and shortness of breath it can be life threatening. In fact, the World Health Organization estimates that COPD will become the third-leading cause of death globally by 2030. This staggering statistic speaks volumes, especially considering that COPD is treatable, although not curable.

At Janssen, we have made great strides to deepen our understanding of patient needs and build a strong network of skilled scientists and experts with deep disease understanding, while seeking collaborative efforts to develop future treatments that are safe, effective and accessible for patients. With a portfolio of promising therapies, Janssen strives to go beyond the current standard of care to not only treat the core symptoms of disease, but one day stop disease progression or even prevent COPD.

Read More

November 17th, 2014

Expanding Access for the World’s Most Vulnerable Patients

By Dr. Paul Stoffels, Chief Scientific Officer, and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson

Access to essential medical treatment and care remains a significant challenge for patients around the world, particularly in countries where resources are limited, healthcare workers are few, and large populations live in poverty. As a physician, I’ve seen first-hand the sheer unmet medical need, and as a business leader, I feel fortunate to work for a company that is dedicated to delivering access to medicines and care to these countries.

Today’s publication of the fourth biannual Access to Medicine Index (ATMI) reports that industry has made significant progress in improving access to safe, effective medicines and vaccines in developing countries. It is heartening to hear the progress we are making, including at Johnson & Johnson, a company that has a longstanding commitment to global health. We continue to make a difference in enhancing access and advancing healthcare for the long-term for the most vulnerable patients.

Ensuring access to our products is at the heart of all that we do. This drives our relentless commitment to continuously innovate and explore new access pathways for our transformational medicines, vaccines, and diagnostics. We’ve made great progress since 2012, thanks in part to the establishment of new, and the expansion of existing, collaborations with key partners.

Read More

November 14th, 2014

Celebrating our Innovation Superstars

by Seema Kumar, Vice President of Innovation, Global Health and Policy Communication, Johnson & Johnson

The 2014 Johnson Medal Recipients pose for a photo with Chief Scientific Officer Dr. Paul Stoffels

The 2014 Johnson Medal Recipients pose for a photo with Chief Scientific Officer Dr. Paul Stoffels

In today’s day and age, we focus much public attention on pop culture celebrities: actors, musicians, athletes. The unsung superstars are the scientists, technologists, and engineers whose relentless pursuit of knowledge and innovation saves and improves lives of people all over the world.

This week, Johnson & Johnson turned our scientists into superstars as we celebrated the 37th Johnson Medal Awards. Eighteen innovators received the Johnson Medal, the most prestigious award given for research and development within Johnson & Johnson. Their achievements reminded me of the incredible dedication, passion, and imagination it takes for scientists to do what they do—work through failure after failure and never give up until they discover, develop, and deliver new innovations for all of us.

It takes imagination and risk taking to attempt and successfully land a space probe on a moving comet. And it takes courage and gumption to attempt to cure an untreatable cancer, or produce a device to perform safer heart procedures, or to innovate established consumer brands. Or, to attempt a vaccine for the deadly Ebola virus.

Read More

November 14th, 2014

Gilda’s Club Corporate Vision Award

Editor’s Note: Johnson & Johnson Group Worldwide Chairman Sandi Peterson spoke at Gilda’s Club New York City’s 19th Anniversary Benefits Gala on Thursday evening at the Pierre Hotel in New York. Johnson & Johnson was honored by the group with its Corporate Vision Award. Gilda’s Club New York City, named after comedian Gilda Radner, supports cancer patients and their families. Sandi’s remarks from the event are shared below.

Sandi Peterson Gilda Awards

It is a real pleasure to be here tonight and a true privilege to accept the Gilda’s Club Corporate Vision Award on behalf of Johnson & Johnson. I’m grateful to my J&J colleagues all over the world for the amazing work they do which you are recognizing here tonight — and for the presence of the J&J folks who were able to join us this evening. I also want to say a special thank you to the many friends and colleagues who have come out tonight and made such a good showing to support this great cause.

I’m especially grateful to be sharing this evening with my sons, Geoffrey and Henry. They, more than anyone else, understand why the mission of Gilda’s Club – “To support, educate and empower cancer patients and their families” – resonates with me so deeply.

Read More

November 12th, 2014

Our Commitment to Supplier Diversity

By: Hans Melotte, Chief Procurement Officer, Johnson & Johnson

Hans Melotte accepting the National Minority Supplier Development Council’s (NMSDC) Award

At Johnson & Johnson, we believe that our suppliers are critical to fulfilling our mission to help people live longer, happier and healthier lives. We view our supplier network as an extension of our enterprise and instrumental in living the responsibilities embedded in Our Credo.

We are constantly shaping our supplier base, seeking the optimal balance between the right size supplier base and the right mix of suppliers, with an ultimate objective to attract innovation, ensure our purchased goods and services are of the highest quality, reduce our costs to maintain reasonable prices and provide access to our products and services in geographies around the world. In doing so, our suppliers must have an opportunity to make a fair profit. We also want our supplier base to reflect the communities in which we live and work. This is where we recognize the important role small and diverse suppliers play in the success of our business.

Last week, I had the great honor of accepting the National Minority Supplier Development Council’s (NMSDC) Award for Corporation of the Year in the Innovation sub-category” on behalf of Johnson & Johnson for our long-standing commitment to supplier diversity.

Read More

November 10th, 2014

Meet Our U.S. Military Veterans

Editor’s Note: In honor of Veterans Day, Johnson & Johnson would like to recognize and thank all those who serve, including our employees, many of whom had careers in the military prior to joining our Johnson & Johnson Family of Companies. We also invite you to read a blog post by Courtney Billington, Vice President, Janssen Supply Chain and U.S. Army veteran, on why hiring veterans delivers big business value.

 

Jimmy E. Anderson, Jr.
Regional Business Director, Central Region Gastroenterology & Academic, Janssen Biotech, Inc.
2nd Lieutenant, Platoon Leader, US Army National Guard

Robert Armstrong
Machinists Mater First Class, U.S. Navy

Ben Berkowick
Regional Business Director, Biosense Webster, Inc.
LT., U.S.

Read More

November 10th, 2014

LATISM14: Deepening Relationships with the Latino Community

by Susan Can, Senior Director, Corporate Equity and Strategic Partnerships

#LATISM14

This week, Johnson & Johnson will head to Anaheim as we celebrate our fourth consecutive year as title sponsor of the LATISM (Latinos in Social Media) conference.

LATISM is the largest organization for Latinos and Latinas engaged in social media, dedicated to advancing the social, civic and economic status of the Latino community.

We are proud to partner with LATISM year after year because the Latino community shares many of the same values with Johnson & Johnson: a commitment to families and children, and a passion for social good and serving communities. These shared values will be highlighted in everything we’re doing at LATISM this year. Here’s a sneak peek of what we have planned.

On Friday, November 14 at 9 a.m. PST/noon EST, we’ll be hosting a breakfast panel entitled Raising Caring Children: How To Make Social Good A Family Value. Joining me on stage will be parents, experts and our partner, GirlUp. We’ll have an open conversation about how parents can teach kids about giving back and encourage them to be active contributors to their communities well into adulthood. Our corporate Twitter handle, @JNJCares, will be live tweeting this event.

Read More

November 10th, 2014

Hiring Veterans Delivers Big Business Value

by Courtney Billington, Vice President, Janssen Supply Chain, Janssen Pharmaceutical Companies of Johnson & Johnson

Editor’s note: This article was originally published on Forbes.com.

Courtney Billington Veteran US Army

If I could do one thing this Veterans Day, it is this: help businesses see how veterans can help them.

With the U.S. military’s involvement in the conflict in Iraq drawing down significantly since 2011 and the one in Afghanistan drawing to a close as well, there are many more veterans entering the workforce. Unfortunately, the U.S. jobless rate for recent veterans is substantially higher than the national average. These men and women have provided a vital service to our country – and many have risked their lives to help preserve our way of life. Don’t we owe it to them to help our veterans reintegrate into the workforce?

Am I talking as a veteran? Yes, I am. I am proud to be a U.S. Army veteran, so I am understandably concerned about the unemployment statistics I see. But I am also speaking as the vice president of a global pharmaceutical organization. In my position, what I have observed is this: when hiring, many managers (across all industries) neglect to consider veterans as potential hires because they can’t read between the lines of a military resume to see the valuable skills vets can bring to the corporate table.

Read More